Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Neuropharmacology > PD and Movement Disorders > Flashcards

PD and Movement Disorders Flashcards

1
Q

What are movement disorders caused by?

A

dysfunction within the basal ganglia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are hyperkinetic movement disorders?

A

conditions that are associated with abnormal or increased body movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are hypokinetic movement disorders?

A

conditions that slow down body movements e.g. Parkinson’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 5 main categories of abnormal movement disorders?

A
  • tremor – involuntary oscillating movement
  • chorea – brief, semi-directed, non-rhythmic, dance-like movements
  • dystonia – sustained or repetitive movements that result in twisting or other abnormal postures of the body
  • myoclonus – rapid, lightning-like twitch of a muscle group that results in a brief jerk
  • tics – sudden, repetitive, non-rhythmic movement or vocalisation involving discrete muscle groups
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is PD?

A

a hypokinetic extrapyramidal motor disorder characterised by bradykinesia, rigidity and tremor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the secondary manifestations of PD?

A
  • shuffling gait
  • mask like face
  • sialorrhea
  • autonomic dysfunction
  • dementia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are symptoms of end-stage PD?

A
  • rigid
  • unable to move
  • unable to breath properly
  • succumbs to chest infections/embolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the most common form of PD?

A

primary idiopathic PD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What can secondary PD be caused by?

A
  • stroke
  • viral infections
  • vascular lesions
  • drugs
  • gene mutations (Parkin, α-synuclein)
  • neurotoxin (MPTP)
  • the environment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the neuronal damage of PD?

A

selective loss of the pigmented, dopaminergic neurons in the substantia nigra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the neuronal damage of PD caused by?

A
  • Lewy bodies
  • excitotoxicity
  • mitochondrial dysfunction
  • oxidative stress
  • inflammation
  • apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are Lewy bodies?

A

misfolding and aggregation of α-synuclein that causes it to degrade within the cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the normal function of α-synculein?

A

vesicle recycling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does a pathological specimen from a PD patient compared to a normal control demonstrate?

A
  • reduction of pigment in SNc
  • reduced number of cells in SNc
  • Lewy bodies within melanised dopamine neurons
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the 4 steps of the SN pathway in PD?

A
  1. destruction of substantia nigra prevents inhibitory action of dopamine on striatum D2 receptors
  2. striatum inhibits GPe
  3. GPe is unable to inhibit STN
  4. STN excites GPi which inhibits the thalamus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the 3 drug types used in PD?

A
  • dopamine agents e.g. dopamine precursor, peripheral decarboxylase inhibitor, dopamine agonist, COMT inhibitor and MAO-B inhibitor
  • non-dopaminergic agents e.g. anticholinergic, anti-glutamergic and GABAergic
  • others e.g. atypical neuroleptic
17
Q

What is the mechanism of action of levodopa?

A

transported into the CNS and converted to dopamine (also can be converted in the periphery)

18
Q

What are the effects of levodopa?

A
  • ameliorates all motor symptoms of PD
  • causes significant peripheral dopaminergic effects
19
Q

Why is levodopa not always used as the first drug to treat PD?

A

due to its potential of long-term complications (tolerance)

20
Q

What is levodopa metabolised by?

A

decarboxylase

21
Q

Why is levodopa administered alongside carbidopa?

A
  • carbidopa inhibits peripheral metabolism of levodopa to dopamine
  • reduces required dosage and toxicity
  • more levodopa reaches the brain
  • carbidopa does not enter CNS
22
Q

What are strengths of levodopa?

A
  • most effective symptomatic therapy in PD
  • acceptable tolerability profile
  • improvements in quality of life seen in short term
23
Q

What are limitations of levodopa?

A
  • short half life (~1 hour)
  • only a small % reaches the brain
  • early wearing-off leading to reduced quality of life
  • motor fluctuations and dyskinesia will develop over longterm treatment
24
Q

What is the mechanism of action of the dopamine agonist pramipexole?

A

direct agonist at D2 receptors (non-ergot)

25
Q

What are the effects of pramipexole?

A
  • reduces PD symptoms
  • smooths out fluctuations in levodopa response
26
Q

What are the side effects of pramipexole?

A
  • nausea and vomiting
  • postural hypotension
  • dyskinesia
  • confusion
  • impulse control disorders
  • sleepiness
27
Q

What is the mechanism of action of the MAO inhibitor selegiline?

A
  • inhibits MAO-B selectively
  • higher doses inhibit MAO-A
28
Q

What are the effects of selegiline?

A
  • increases dopamine stores in neurons
  • smooths levodopa response
  • may have neuroprotective mechanisms
29
Q

What are the side effects of selegiline?

A

serotonin syndrome with SSRIs and TCAs

30
Q

What is the mechanism of action of the COMT inhibitor entacapone?

A

inhibits COMT in periphery and does not enter CNS

31
Q

What are the effects of entacapone?

A

reduces metabolism of levodopa and prolongs its action

32
Q

What are the side effects of entacapone?

A

nausea, dyskinesia and confusion

33
Q

What do anticholinergic drugs aim to do?

A

decrease ACh levels and increase dopamine levels

34
Q

What is the mechanism of action of the anticholinergic benztropine?

A

antagonist at M receptors in basal ganglia

35
Q

What are the effects of benztropine?

A

reduces tremor and rigidity with little effect on bradykinesia

36
Q

What are side effects of benztropine?

A

typical antimuscarinic effects e.g. sedation, mydriasis, urinary retention, constipation, confusion and dry mouth

37
Q

What do dopaminergic neurons originating in the SN normally do?

A

inhibit the GABAergic output from the striatum (cholinergic neurons exert an excitatory effect)

38
Q

Give examples of other PD drugs

A
  • anti-glutaminergic drugs e.g. amantadine
  • antipsychotic drugs e.g. quetiapine
  • GABAergic drugs e.g. benzodiazepines (lorazepam and clonazepam)
39
Q

Give examples of newer PD drug targets

A
  • enhance the clearance of misfolded proteins and reduce their transmission and thereby the progress of neuronal damage
  • improve the function of mitochondria
  • target neuroinflammation

Neuropharmacology (12 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions